Astrana Health (ASTH) vs Aveanna Healthcare (AVAH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Aveanna Healthcare (AVAH) has outperformed Astrana Health (ASTH) over the past year, gaining 39.0% versus a gain of 23.4%. Over five years, AVAH leads with a +82.0% price change compared with -47.5% for ASTH. Aveanna Healthcare is the larger company by market cap ($2.67 billion vs $1.86 billion), about 1.4 times the size, while Astrana Health is growing revenue faster (+56.4% vs +20.2%).
On valuation, Astrana Health trades at a lower forward P/E (10.3x vs 13.5x for Aveanna Healthcare). Aveanna Healthcare converts more of its revenue into profit, with a net margin of 9.2% versus 0.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | AVAH |
|---|---|---|
| Share price | $37.55 | $12.25 |
| Market cap | $1.86B | $2.67B |
| 1-day change | +4.68% | +0.08% |
| YTD return | +51.35% | +49.94% |
| 1-year return | +23.44% | +39.05% |
| 5-year return | -47.48% | +82.02% |
| P/E ratio (TTM) | 45.24 | 9.72 |
| Forward P/E | 10.33 | 13.50 |
| EPS (TTM) | $0.83 | $1.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.18B | $2.43B |
| Revenue growth (YoY) | +56.39% | +20.19% |
| Net income (latest FY) | $22.49M | $225.03M |
| Gross margin | 10.73% | 33.31% |
| Operating margin | 2.47% | 10.54% |
| Net margin | 0.71% | 9.25% |
| 52-week high | $51.60 | $14.71 |
| 52-week low | $18.08 | $5.93 |
| Distance from 52-week high | -27.23% | -16.72% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +37.60% | +21.22% |
| Average volume | 460.33K | 3.08M |
| Shares outstanding | 49.60M | 218.29M |
| Employees | 3,000 | 3,500 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVAH has outperformed ASTH by 15.6 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (45.2x vs 9.7x trailing P/E).
- Aveanna Healthcare is more profitable, keeping 9.2 cents of every revenue dollar as net income versus 0.7 cents for Astrana Health.
- Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs +20.19%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Healthcare · Medical Care Facilities · 3,000 employees
About Aveanna Healthcare
AVAH stock →Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Healthcare · Medical Care Facilities · 3,500 employees
ASTH vs AVAH FAQ
Which is bigger, Astrana Health or Aveanna Healthcare?
Aveanna Healthcare (AVAH) is larger, with a market capitalization of $2.67B compared with $1.86B for Astrana Health (ASTH).
Which stock has performed better over the past year, ASTH or AVAH?
AVAH returned +39.05% over the past 12 months, compared with +23.44% for ASTH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or AVAH?
AVAH has the lower trailing P/E at 9.7, versus 45.2 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Astrana Health and Aveanna Healthcare in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.